Sheldon D. Fields

Last updated
Sheldon D. Fields
Born
Sheldon Darcy Fields

New York City, New York, US
NationalityAmerican
Alma materBinghamton University (B.S. and M.S.) and University of Pennsylvania (Ph.D.)

Sheldon D. Fields is a Registered Professional Nurse, Family Nurse Practitioner, educator, researcher, health policy analyst, and nurse entrepreneur who is known for his work in the field of behavioral health research specializing in the area of HIV/AIDS prevention.

Contents

Early life and education

Fields was born in Brooklyn, New York, the youngest child of six children raised by a single mother. Fields attended public schools and lived in Brooklyn until the age of 17. Sheldon attended Clara Barton High School for Health Professionals with the intention of going to medical school in the future. Instead, he discovered his love of nursing.

At the age of 17, Sheldon began his college education at the State University of New York (now known as Binghamton University). Fields graduated in 1991 and started his first job as a nurse at the Sloan Cancer Center in New York City. It was there that Fields first was exposed to the HIV/AIDS population. Working at Sloan Cancer Center, Fields also worked closely with Nurse Practitioners and decided to return to school to receive his advanced degree in nursing. In 1993, Fields returned to Binghamton University to complete a master's in family nursing with certification as Family Nurse Practitioner. While studying for his master's degree, Fields researched intimate partner violence. His mentor, Dr. Theresa Grabo, encouraged him to pursue a Ph.D., and Fields went on to attend the University of Pennsylvania, his mentor's alma mater, graduating with a Ph.D. in Nursing Science in 2000.

Professional life

Fields's specialty is behavioral health, in particular HIV/AIDS prevention. He has produced contributions including scholarly articles, book chapters, seminars, webinars, newspaper articles, and television appearances. Many of his contributions focus on the young minority HIV/AIDS population.

Fields has conducted national-level research within the HIV Vaccine Trials Network (HVTN) and the HIV Prevention Trials Network(HPTN). Along with these endeavors, Fields began his career as an assistant professor at Binghamton University from 2000 to 2001. While in Rochester, New York, in 2009, he was selected for the highly competitive and prestigious Robert Wood Johnson Health Policy Fellowship, which allowed him to work in the office of United States Senator Barbara Mikulski (D-MD). Fields supported Senator Mikulski's work on the aging subcommittee of the Senate HELP committee during the height of the historic healthcare reform legislation. [1] Shortly after, Fields was promoted to associate professor in the School of Nursing at the University of Rochester.

In late 2011, Fields became an associate professor at Florida International University's Nicole Wertheim College of Nursing and Health Sciences and was the first assistant dean of clinical affairs and health policy, as well as the co-director of the Doctor of Nursing Practice (DNP) program. Fields left Florida in January 2015 to be the dean of the Mervyn M. Dymally School of Nursing at Charles R. Drew University of Medicine and Science in Los Angeles, California. This appointment made Fields one of the youngest nursing deans in the country. Fields is also one of very few people of color (Afro-Latino) or men to have led a school of nursing. Fields left Drew in 2016, and in January 2017 he began work as dean of New York Institute of Technology's School of Health Professions, where he oversaw five allied health degree programs. [2] until August 2019. He is founder and CEO of his own healthcare consultant firm that he started in 2016.

Fields has been cited in several newspapers, including the Sun-Sentinel [3] and the Bay Area Reporter . [4] He has also written a chapter in the book Disaster Nursing and Emergency Preparedness. [5]

Awards and honors

Works

Journal articles

Related Research Articles

<span class="mw-page-title-main">HIV/AIDS in the United States</span> HIV/AIDS epidemic in the United States

The AIDS epidemic, caused by HIV, found its way to the United States between the 1970s and 1980s, but was first noticed after doctors discovered clusters of Kaposi's sarcoma and pneumocystis pneumonia in homosexual men in Los Angeles, New York City, and San Francisco in 1981. Treatment of HIV/AIDS is primarily via the use of multiple antiretroviral drugs, and education programs to help people avoid infection.

Down-low is an African-American slang term specifically used within the African-American community that typically refers to a sexual subculture of Black men who usually identify as heterosexual but actively seek sexual encounters and relations with other men, practice gay cruising, and frequently don a specific hip-hop attire during these activities. They generally avoid disclosing their same-sex sexual activities, even if they have female sexual partner(s), they are married to a woman, or they are single. The term is also used to refer to a related sexual identity. Down-low has been viewed as "a type of impression management that some of the informants use to present themselves in a manner that is consistent with perceived norms about masculine attribute, attitudes, and behavior".

Men who have sex with men (MSM) refers to all men who engage in sexual activity with other men, regardless of their sexual orientation or sexual identity. The term was created by epidemiologists in the 1990s, to better study and communicate the spread of sexually transmitted infections such as HIV/AIDS between all sexually active males, not strictly those identifying as gay, bisexual, pansexual or various other sexualities, but also for example male prostitutes. The term is often used in medical literature and social research to describe such men as a group. It does not describe any specific kind of sexual activity, and which activities are covered by the term depends on context. An alternative term, males who have sex with males is sometimes considered more accurate in cases where those described may not be legal adults.

HIV/AIDS in China can be traced to an initial outbreak of the human immunodeficiency virus (HIV) first recognized in 1989 among injecting drug users along China's southern border. Figures from the Chinese Center for Disease Control and Prevention, World Health Organization, and UNAIDS estimate that there were 1.25 million people living with HIV/AIDS in China at the end of 2018, with 135,000 new infections from 2017. The reported incidence of HIV/AIDS in China is relatively low, but the Chinese government anticipates that the number of individuals infected annually will continue to increase.

Professor Sheila Dinotshe Tlou is a Botswana nurse, specialist in HIV/AIDS and women's health, and a nursing educator. She was Minister of Health from 2004 to 2008. Professor Tlou is a distinguished advocate for human resources for health issues. She is a recognized visionary leader and champion.

The history of HIV/AIDS in Australia is distinctive, as Australian government bodies recognised and responded to the AIDS pandemic relatively swiftly, with the implementation of effective disease prevention and public health programs, such as needle and syringe programs (NSPs). As a result, despite significant numbers of at-risk group members contracting the virus in the early period following its discovery, Australia achieved and has maintained a low rate of HIV infection in comparison to the rest of the world.

Although Senegal is a relatively underdeveloped country, HIV prevalence in the general population is low at around 0.08 per 1000 people, under 1% of the population. This relatively low prevalence rate is aided by the fact that few people are infected every year – in 2016, 1100 new cases were reported vs 48,000 new cases in Brazil. Senegal's death due to HIV rate, particularly when compared it to its HIV prevalence rate, is relatively high with 1600 deaths in 2016. Almost two times as many women were infected with HIV as men in 2016, and while almost three times as many women were receiving antiretroviral therapy (ARV) as men, only 52% of HIV positive people in Senegal received ARV treatment in 2016.

HIV/AIDS in Eswatini was first reported in 1986 but has since reached epidemic proportions. As of 2016, Eswatini had the highest prevalence of HIV among adults aged 15 to 49 in the world (27.2%).

With less than 0.1 percent of the population estimated to be HIV-positive, Bangladesh is a low HIV-prevalence country.

The Dominican Republic has a 0.7 percent prevalence rate of HIV/AIDS, among the lowest percentage-wise in the Caribbean region. However, it has the second most cases in the Caribbean region in total web|url=http://www.avert.org/caribbean-hiv-aids-statistics.htm |title=Caribbean HIV & AIDS Statistics|date=21 July 2015}}</ref> with an estimated 46,000 HIV/AIDS-positive Dominicans as of 2013.

HIV/AIDS in El Salvador has a less than 1 percent prevalence of the adult population reported to be HIV-positive. El Salvador therefore is a low-HIV-prevalence country. The virus remains a significant threat in high-risk communities, such as commercial sex workers (CSWs) and men who have sex with men (MSM).

Honduras is the Central American country most adversely affected by the HIV/AIDS epidemic. It is estimated that the prevalence of HIV among Honduran adults is 1.5%.

With less than 1 percent of the population estimated to be HIV-positive, Egypt is a low-HIV-prevalence country. However, between the years 2006 and 2011, HIV prevalence rates in Egypt increased tenfold. Until 2011, the average number of new cases of HIV in Egypt was 400 per year, but in 2012 and 2013, it increased to about 600 new cases, and in 2014, it reached 880 new cases per year. According to 2016 statistics from UNAIDS, there are about 11,000 people currently living with HIV in Egypt. The Ministry of Health and Population reported in 2020 over 13,000 Egyptians are living with HIV/AIDS. However, unsafe behaviors among most-at-risk populations and limited condom usage among the general population place Egypt at risk of a broader epidemic.

<span class="mw-page-title-main">HIV-affected community</span> Medical condition

The affected community is composed of people who are living with HIV and AIDS, plus individuals whose lives are directly influenced by HIV infection. This originally was defined as young to middle aged adults who associate with being gay or bisexual men, and or injection drug users. HIV-affected community is a community that is affected directly or indirectly affected by HIV. These communities are usually influenced by HIV and undertake risky behaviours that lead to a higher chance of HIV infection. To date HIV infection is still one of the leading cause of deaths around the world with an estimate of 36.8 million people diagnosed with HIV by the end of 2017, but there can particular communities that are more vulnerable to HIV infection, these communities include certain races, gender, minorities, and disadvantaged communities. One of the most common communities at risk is the gay community as it is commonly transmitted through unsafe sex. The main factor that contributes to HIV infection within the gay/bisexual community is that gay men do not use protection when performing anal sex or other sexual activities which can lead to a higher risk of HIV infections. Another community will be people diagnosed with mental health issues, such as depression is one of the most common related mental illnesses associated with HIV infection. HIV testing is an essential role in reducing HIV infection within communities as it can lead to prevention and treatment of HIV infections but also helps with early diagnosis of HIV. Educating young people in a community with the knowledge of HIV prevention will be able to help decrease the prevalence within the community. As education is an important source for development in many areas. Research has shown that people more at risk for HIV are part of disenfranchised and inner city populations as drug use and sexually transmitted diseases(STDs) are more prevalent. People with mental illnesses that inhibit making decisions or overlook sexual tendencies are especially at risk for contracting HIV.

Discrimination against people with HIV/AIDS or serophobia is the prejudice, fear, rejection, and stigmatization of people with HIV/AIDS. Marginalized, at-risk groups such as members of the LGBTQ+ community, intravenous drug users, and sex workers are most vulnerable to facing HIV/AIDS discrimination. The consequences of societal stigma against PLHIV are quite severe, as HIV/AIDS discrimination actively hinders access to HIV/AIDS screening and care around the world. Moreover, these negative stigmas become used against members of the LGBTQ+ community in the form of stereotypes held by physicians.

Since reports of emergence and spread of the human immunodeficiency virus (HIV) in the United States between the 1970s and 1980s, the HIV/AIDS epidemic has frequently been linked to gay, bisexual, and other men who have sex with men (MSM) by epidemiologists and medical professionals. It was first noticed after doctors discovered clusters of Kaposi's sarcoma and pneumocystis pneumonia in homosexual men in Los Angeles, New York City, and San Francisco in 1981. The first official report on the virus was published by the Center for Disease Control (CDC) on June 5, 1981, and detailed the cases of five young gay men who were hospitalized with serious infections. A month later, The New York Times reported that 41 homosexuals had been diagnosed with Kaposi's sarcoma, and eight had died less than 24 months after the diagnosis was made.

With an estimated 120,000 people living with HIV/AIDS, the HIV/AIDS epidemic in Colombia is consistent with the epidemic in much of Latin America as a whole, both in terms of prevalence of infection and characteristics of transmission and affected populations. Colombia has a relatively low rate of HIV infection at 0.4%. Certain groups, particularly men who have sex with men, bear the burden of significantly higher rates of infection than the general population. Colombia's health care system and conception of a "right to health", created by the T-760 decision of 2008, have revolutionized access to HIV treatment. Despite this, the quality of health insurance and treatment for HIV has often been disputed.

<span class="mw-page-title-main">Jennifer S. Hirsch</span>

Jennifer Hirsch is a professor at the Mailman School of Public Health at Columbia University. She is the deputy chair for doctoral studies in the Department of Sociomedical Studies, and co-director of Columbia's Center for Population Research. Hirsch also co-directed the Sexual Health Initiative to Foster Transformation. Her work spans topics such as gender, human sexuality, and public health. Her book, A Courtship After Marriage: Sexuality and Love in Mexican Transnational Families, which has been used widely in college classrooms, explores the lives of Mexican women in Atlanta and rural Mexico, with a focus on changing ideas of marriage among Latinx couples. Hirsch served on the Board of Directors of Jews for Racial and Economic Justice from 2014-2020 and is a member of B'nai Jeshurun

<span class="mw-page-title-main">LGBT health in South Korea</span>

The health access and health vulnerabilities experienced by the lesbian, gay, bisexual, transgender, queer or questioning, intersex, asexual (LGBTQIA) community in South Korea are influenced by the state's continuous failure to pass anti-discrimination laws that prohibit discrimination based on sexual orientation and gender identity. The construction and reinforcement of the South Korean national subject, "kungmin," and the basis of Confucianism and Christian churches perpetuates heteronormativity, homophobia, discrimination, and harassment towards the LGBTQI community. The minority stress model can be used to explain the consequences of daily social stressors, like prejudice and discrimination, that sexual minorities face that result in a hostile social environment. Exposure to a hostile environment can lead to health disparities within the LGBTQI community, like higher rates of depression, suicide, suicide ideation, and health risk behavior. Korean public opinion and acceptance of the LGBTQI community have improved over the past two decades, but change has been slow, considering the increased opposition from Christian activist groups. In South Korea, obstacles to LGBTQI healthcare are characterized by discrimination, a lack of medical professionals and medical facilities trained to care for LGBTQI individuals, a lack of legal protection and regulation from governmental entities, and the lack of medical care coverage to provide for the health care needs of LGBTQI individuals. The presence of Korean LGBTQI organizations is a response to the lack of access to healthcare and human rights protection in South Korea. It is also important to note that research that focuses on Korean LGBTQI health access and vulnerabilities is limited in quantity and quality as pushback from the public and government continues.

References

  1. HIV Researcher Heads to Washington to Study Health Policy. Sept 9, 2009. www.urmc.rochester.edu. Retrieved on 2012-11-3.
  2. "Sheldon Fields to Lead NYIT School of Health Professions," Newswise, 4 January 2017. Retrieved on 2017-01-04.
  3. Nurse practitioners tackling more "doctor" tasks. May 5, 2012. Sun-sentinel.com. Retrieved on 2012-11-3
  4. HIV rages among gay black men. Aug 2, 2012. Ebar.com. Retrieved on 2012-11-3
  5. Sheldon Fields. "Chapter 35: Caring for Patients with HIV and AIDS Following a Disaster" Disaster Nursing and Emergency Preparedness: For Chemical, Biological, and Radiological Terrorism and Other Hazards (3 ed). Ed. Tener Goodwin Veenema, PhD, MPH, MS, CPNP. Springer Publishing Company, 2012. 647-654.